UK markets closed

Sunho Biologics Inc (2898.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
6.700-0.200 (-2.90%)
At close: 04:08PM HKT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
Total revenue
208
208
1,731
Cost of revenue
70
70
1,258
Gross profit
138
138
473
Operating expenses
Research development
43,041
43,041
53,171
Selling general and administrative
40,701
40,701
5,558
Total operating expenses
66,416
66,416
46,680
Operating income or loss
-66,278
-66,278
-46,207
Interest expense
692
692
5,074
Income before tax
-132,701
-132,701
-51,988
Income tax expense
0
0
0
Income from continuing operations
-132,701
-132,701
-51,988
Net income
-132,701
-132,701
-51,988
Net income available to common shareholders
-132,701
-132,701
-51,988
Basic EPS
-0.85
-
-0.33
Diluted EPS
-0.85
-
-0.33
Basic average shares
156,667
-
156,667
Diluted average shares
156,667
-
156,667